Novartis Ag

Inventio Ag

Markus Weiss

Donald Johns

Kevin Hall McAllister

Cristina Lopez-Lopez

Kevin Hall Mcallister

Dominik Feuerbach

Baltazar Gomez-Mancilla

Yunsheng He

Lisa Sandford

Nicole Pezous

Christer Halldin

Judit Sovago

Werner Engel

Markus Fendt

Sjoerd Johannes Finnema

The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment.

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.

Use of alpha 7 nicotinic acetylcholine receptor agonists

A method and a device for maintenance of an elevator or escalator installation includes an interface for connection of a controller of the installation with a display and control unit for display of operating parameters or for input of control commands and data, and connection equipment for creating a data connection with a maintenance center. Data and parameters stored in the maintenance center can be transferred to the display and control unit by the data connection after an identification check. A fault log with a specification of operating faults and/or a specification of the replacement parts coming into question for rectification of the operating faults can be produced, which is transferred by the data connection from the display and control unit to the maintenance center, can be produced for example to cause ordering of missing replacement parts.

Generating elevator or escalator installation fault log

Growing community of inventors

Basel, Switzerland

Markus Weiss